Showing results (191-200 of 226) with videos related to
Sort By:
Pageof 23
Free Radical Biology & Medicine|August 2, 2019
Plasma cysteine/cystine and glutathione/glutathione disulfide redox potentials in HIV and COPD patientsWalter H Watson, Jeffrey D Ritzenthaler, Paula Peyrani, et al.American Journal of Infection Control|September 17, 2017
Methods for computational disease surveillance in infection prevention and control: Statistical process control versus Twitter's anomaly and breakout detection algorithmsTimothy L Wiemken, Stephen P Furmanek, William A Mattingly, et al.Pneumonia (Nathan Qld.)|October 24, 2019
The upper respiratory tract microbiome of hospitalised patients with community-acquired pneumonia of unknown aetiology: a pilot studyTimothy L Wiemken, Venkatakrishna Rao Jala, Robert R Kelley, et al.Journal of Medical Microbiology|March 21, 2020
A pooled analysis of patients with wound infections in the Phase 3 REVIVE trials: randomized, double-blind studies to evaluate the safety and efficacy of iclaprim versus vancomycin for treatment of acute bacterial skin and skin structure infectionsStephanie Noviello, G Ralph Corey, Thomas L Holland, et al.Eclinicalmedicine|December 4, 2025
Omadacycline versus moxifloxacin for community-acquired bacterial pneumonia (OPTIC-2): a phase 3b, randomised, double-blind, multicentre, controlled, noninferiority trialThomas M File, Keith S Kaye, Skliarov Ihor, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 2, 2011
Severity of disease and clinical outcomes in patients with hospital-acquired pneumonia due to methicillin-resistant Staphylococcus aureus strains not influenced by the presence of the Panton-Valentine leukocidin genePaula Peyrani, Marty Allen, Timothy L Wiemken, et al.The Lancet. Infectious Diseases|January 25, 2011
Implementation of guidelines for management of possible multidrug-resistant pneumonia in intensive care: an observational, multicentre cohort studyDaniel H Kett, Ennie Cano, Andrew A Quartin, et al.Clinical Therapeutics|January 31, 2012
Incidence of nephrotoxicity and association with vancomycin use in intensive care unit patients with pneumonia: retrospective analysis of the IMPACT-HAP DatabaseEnnie L Cano, Nadia Z Haque, Verna L Welch, et al.Vaccine|March 12, 2014
The effectiveness of the polysaccharide pneumococcal vaccine for the prevention of hospitalizations due to Streptococcus pneumoniae community-acquired pneumonia in the elderly differs between the sexes: results from the Community-Acquired Pneumonia Organization (CAPO) international cohort studyTimothy L Wiemken, Ruth M Carrico, Sabra L Klein, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 23, 2012
IDSA clinical practice guideline for acute bacterial rhinosinusitis in children and adultsAnthony W Chow, Michael S Benninger, Itzhak Brook, et al.Pageof 23